Literature DB >> 21345961

Environmental and antigen receptor-derived signals support sustained surveillance of the lungs by pathogen-specific cytotoxic T lymphocytes.

Young-Tae Lee1, Jenny E Suarez-Ramirez, Tao Wu, Jason M Redman, Keith Bouchard, Gregg A Hadley, Linda S Cauley.   

Abstract

Viral infections often gain access to the body of their host by exploiting areas of natural vulnerability, such as the semipermeable surfaces of mucosal tissues which are adapted for adsorption of nutrients and other diffusible molecules. Once the microbes have crossed the epithelial barrier, they can disperse to other tissues where eradication may not be possible. The best opportunity for successful immune intervention is immediately after infection while the pathogen is confined to a localized area of the body. Cytotoxic T lymphocytes (CTL) which reside at the site where the infection begins can make an important contribution to immunity by reducing early dissemination of the infection. Because the lungs provide easy access points for many pathogens to enter the body, they require protection from many complementary mechanisms, including pathogen-specific cytotoxic T cells. In this study we show that an enduring response to pathogen-derived peptide antigens facilitates sustained surveillance of the lungs by pathogen-specific CTL during the recovery from influenza virus infection. Our studies show that these processed peptide antigens reinforce expression of two homing receptors (CD69 and CD103) which help recently activated virus-specific CTL colonize the lungs during a mild inflammatory response. We suggest that this requirement for prolonged antigen presentation to reinforce local CTL responses in the lungs explains why protective cellular immunity quickly declines following influenza virus infection and other viral infections that enter the body via mucosal tissues.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21345961      PMCID: PMC3126261          DOI: 10.1128/JVI.02493-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  A previously unrecognized H-2D(b)-restricted peptide prominent in the primary influenza A virus-specific CD8(+) T-cell response is much less apparent following secondary challenge.

Authors:  G T Belz; W Xie; J D Altman; P C Doherty
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Phenotypic and functional characteristics of hematopoietic cell lineages in CD69-deficient mice.

Authors:  P Lauzurica; D Sancho; M Torres; B Albella; M Marazuela; T Merino; J A Bueren; C Martínez-A; F Sánchez-Madrid
Journal:  Blood       Date:  2000-04-01       Impact factor: 22.113

3.  Measuring the diaspora for virus-specific CD8+ T cells.

Authors:  D R Marshall; S J Turner; G T Belz; S Wingo; S Andreansky; M Y Sangster; J M Riberdy; T Liu; M Tan; P C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

4.  Activated antigen-specific CD8+ T cells persist in the lungs following recovery from respiratory virus infections.

Authors:  R J Hogan; E J Usherwood; W Zhong; A A Roberts; R W Dutton; A G Harmsen; D L Woodland
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

5.  Memory T cell populations in the lung airways are maintained by continual recruitment.

Authors:  Kenneth H Ely; Tres Cookenham; Alan D Roberts; David L Woodland
Journal:  J Immunol       Date:  2006-01-01       Impact factor: 5.422

6.  Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody.

Authors:  A Porgador; J W Yewdell; Y Deng; J R Bennink; R N Germain
Journal:  Immunity       Date:  1997-06       Impact factor: 31.745

7.  Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease.

Authors:  L Gorelik; R A Flavell
Journal:  Immunity       Date:  2000-02       Impact factor: 31.745

8.  CD69-triggered ERK activation and functions are negatively regulated by CD94 / NKG2-A inhibitory receptor.

Authors:  A Zingoni; G Palmieri; S Morrone; M Carretero; M Lopez-Botel; M Piccoli; L Frati; A Santoni
Journal:  Eur J Immunol       Date:  2000-02       Impact factor: 5.532

9.  Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migration.

Authors:  David J Zammit; Damian L Turner; Kimberly D Klonowski; Leo Lefrançois; Linda S Cauley
Journal:  Immunity       Date:  2006-04       Impact factor: 31.745

10.  CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs.

Authors:  Lawrence R Shiow; David B Rosen; Nadezda Brdicková; Ying Xu; Jinping An; Lewis L Lanier; Jason G Cyster; Mehrdad Matloubian
Journal:  Nature       Date:  2006-03-08       Impact factor: 49.962

View more
  97 in total

1.  Lymphocytic choriomeningitis virus persistence promotes effector-like memory differentiation and enhances mucosal T cell distribution.

Authors:  Lalit K Beura; Kristin G Anderson; Jason M Schenkel; Jeremiah J Locquiao; Kathryn A Fraser; Vaiva Vezys; Marion Pepper; David Masopust
Journal:  J Leukoc Biol       Date:  2014-11-13       Impact factor: 4.962

2.  Memory B cells in the lung participate in protective humoral immune responses to pulmonary influenza virus reinfection.

Authors:  Taishi Onodera; Yoshimasa Takahashi; Yusuke Yokoi; Manabu Ato; Yuichi Kodama; Satoshi Hachimura; Tomohiro Kurosaki; Kazuo Kobayashi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

3.  Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation.

Authors:  Laura K Mackay; Angus T Stock; Joel Z Ma; Claerwen M Jones; Stephen J Kent; Scott N Mueller; William R Heath; Francis R Carbone; Thomas Gebhardt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

4.  Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination.

Authors:  Chiara Nembrini; Armando Stano; Karen Y Dane; Marie Ballester; André J van der Vlies; Benjamin J Marsland; Melody A Swartz; Jeffrey A Hubbell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

Review 5.  Tissue-resident memory T cells: local specialists in immune defence.

Authors:  Scott N Mueller; Laura K Mackay
Journal:  Nat Rev Immunol       Date:  2015-12-21       Impact factor: 53.106

6.  Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection.

Authors:  Tao Wu; Yinghong Hu; Young-Tae Lee; Keith R Bouchard; Alexandre Benechet; Kamal Khanna; Linda S Cauley
Journal:  J Leukoc Biol       Date:  2013-09-04       Impact factor: 4.962

7.  Mucosal Immunization with a pH-Responsive Nanoparticle Vaccine Induces Protective CD8+ Lung-Resident Memory T Cells.

Authors:  Frances C Knight; Pavlo Gilchuk; Amrendra Kumar; Kyle W Becker; Sema Sevimli; Max E Jacobson; Naveenchandra Suryadevara; Lihong Wang-Bishop; Kelli L Boyd; James E Crowe; Sebastian Joyce; John T Wilson
Journal:  ACS Nano       Date:  2019-10-04       Impact factor: 15.881

Review 8.  Tissue-resident lymphocytes: from adaptive to innate immunity.

Authors:  Haoyu Sun; Cheng Sun; Weihua Xiao; Rui Sun
Journal:  Cell Mol Immunol       Date:  2019-01-11       Impact factor: 11.530

9.  Splenic priming of virus-specific CD8 T cells following influenza virus infection.

Authors:  Damian L Turner; Kara L Bickham; Donna L Farber; Leo Lefrançois
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

Review 10.  Programmed T cell differentiation: Implications for transplantation.

Authors:  Rebecca L Crepeau; Mandy L Ford
Journal:  Cell Immunol       Date:  2020-03-29       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.